OIM

Oracle Investment Management Portfolio holdings

AUM $116M
This Quarter Return
-6.02%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$463M
AUM Growth
+$463M
Cap. Flow
+$30.3M
Cap. Flow %
6.54%
Top 10 Hldgs %
95.6%
Holding
15
New
1
Increased
6
Reduced
3
Closed
–

Top Buys

1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$28.5M
2
CI icon
Cigna
CI
$4.67M
3
DERM
Dermira, Inc.
DERM
$3.75M
4
MOTS
Motus GI Holdings, Inc. Common Stock
MOTS
$3M
5
CFRX
ContraFect Corporation
CFRX
$375K

Top Sells

1
QDEL icon
QuidelOrtho
QDEL
$7.02M
2
AMRN
Amarin Corp
AMRN
$1.89M
3
BIOL
Biolase, Inc.
BIOL
$1.47M

Sector Composition

1 Healthcare 96.37%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.95B
$106M 22.78%
1,785,264
-118,294
-6% -$7.02M
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
$99.7M 21.44%
4,356,363
+6,800
+0.2% +$156K
AMRN
3
Amarin Corp
AMRN
$311M
$99.5M 21.39%
5,128,970
-97,610
-2% -$1.89M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$73.3M 15.76%
1,672,950
+651,558
+64% +$28.5M
DERM
5
DELISTED
Dermira, Inc.
DERM
$16.8M 3.62%
1,760,072
+392,636
+29% +$3.75M
MOTS
6
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$11.4M 2.46%
3,766,666
+991,666
+36% +$3M
SLNO icon
7
Soleno Therapeutics
SLNO
$3.6B
$10.7M 2.3%
3,813,558
– –
OPK icon
8
Opko Health
OPK
$1.1B
$8.99M 1.93%
3,686,194
– –
VRML
9
DELISTED
Vermillion, Inc.
VRML
$8.75M 1.88%
9,825,289
– –
BIOL
10
DELISTED
Biolase, Inc.
BIOL
$7.61M 1.64%
5,173,250
-1,000,000
-16% -$1.47M
PACB icon
11
Pacific Biosciences
PACB
$393M
$6.72M 1.45%
1,110,666
– –
CI icon
12
Cigna
CI
$80.3B
$4.67M 1.01%
+29,653
New +$4.67M
AGEN
13
Agenus
AGEN
$133M
$4.23M 0.91%
1,408,918
+50,000
+4% +$150K
CFRX
14
DELISTED
ContraFect Corporation
CFRX
$3.24M 0.7%
6,356,649
+735,450
+13% +$375K
BIIB icon
15
Biogen
BIIB
$19.4B
$1.49M 0.32%
6,368
– –